Literature DB >> 6148947

Inhibitory effects of various drugs on phorbol myristate acetate and n-formyl methionyl leucyl phenylalanine induced O2- production in polymorphonuclear leukocytes.

K Taniguchi, K Takanaka.   

Abstract

To clarify the mechanisms of O2- formation by polymorphonuclear leukocytes (PMNs), the effects of clinically employed drugs on PMNs were investigated by measuring changes in membrane potential and rates of O2- production. These variables were effectively diminished with antihistaminic agents, adrenergic beta-antagonists, and antiarrhythmic drugs when guinea pig peritoneal PMNs were stimulated by either phorbol myristate acetate (PMA) or n-formyl-methionyl-leucyl-phenylalanine (FMLP). The order of potency of the inhibitory effects of these chemicals on the PMA-induced O2- formation was as follows: azelastine (IC50 = 4.1 microM) less than clemastine less than dl-propranolol less than chlorpheniramine maleate less than dichlorisoproterenol less than quinidine less than diphenhydramine less than indomethacin (IC50 greater than 400 microM). Similar phenomena were observed when FMLP was employed instead of PMA, but the FMLP-stimulated O2- production was effectively inhibited by indomethacin. Changes in membrane potential, using the cyanin dye method, also indicated that most of these drugs cancelled functional changes of plasma membrane of PMNs. From these observations, it was demonstrated that changes in membrane potential by the stimuli were essential for the initiation of O2- generation from plasma membrane of PMNs, although the initiation mechanisms were not identical for the two stimuli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148947     DOI: 10.1016/0006-2952(84)90072-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Inhibitory effects of phenyltin compounds on stimulus-induced changes in cytosolic free calcium and plasma membrane potential of human neutrophils.

Authors:  Y Miura; H Matsui
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C.

Authors:  E Middleton; P Ferriola; G Drzewiecki; R D Sofia
Journal:  Agents Actions       Date:  1989-08

Review 3.  Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

4.  Influence of epithelial removal on the antihistaminic activity of azelastine in the guinea-pig airway smooth muscles.

Authors:  Y Kamikawa
Journal:  Agents Actions       Date:  1993-11

5.  Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine.

Authors:  J Schmidt; B Kaufmann; R Lindstaedt; I Szelenyi
Journal:  Agents Actions       Date:  1990-11

6.  The effect of histamine on the oxidative burst of HL60 cells before and after exposure to reactive oxygen species.

Authors:  T L Ching; J G Koelemij; A Bast
Journal:  Inflamm Res       Date:  1995-03       Impact factor: 4.575

7.  Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum.

Authors:  N Chand; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-11

8.  Phospholipase A2 induced airway hyperreactivity to cooling and acetylcholine in rat trachea: pharmacological modulation.

Authors:  N Chand; W Diamantis; T P Mahoney; R D Sofia
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

Review 9.  Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity.

Authors:  M T Smith; J W Yager; K L Steinmetz; D A Eastmond
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.